Immune-related pathologic response (irPR) features and immunotherapeuticresponse score (ITRS) to predict survival following neoadjuvant combined immunotherapy in hepatocellular carcinoma. Development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results